Propanc Biopharma Common Stock Technical Analysis
| PPCB Stock | USD 0.19 0.01 5.00% |
As of the 11th of February 2026, Propanc Biopharma, holds the Risk Adjusted Performance of (0.24), variance of 58.99, and Coefficient Of Variation of (316.00). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Propanc Biopharma,, as well as the relationship between them.
Propanc Biopharma, Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Propanc, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PropancPropanc |
Propanc Biopharma, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Propanc Biopharma,'s pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Propanc Biopharma,.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Propanc Biopharma, on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Propanc Biopharma Common or generate 0.0% return on investment in Propanc Biopharma, over 90 days. Propanc Biopharma, is related to or competes with Telescope Innovations, ImmunoCellular Therapeutics, Cell Source, Zenith Capital, and Hookipa Pharma. Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, ... More
Propanc Biopharma, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Propanc Biopharma,'s pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Propanc Biopharma Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.33) | |||
| Maximum Drawdown | 58.21 | |||
| Value At Risk | (14.89) | |||
| Potential Upside | 7.14 |
Propanc Biopharma, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Propanc Biopharma,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Propanc Biopharma,'s standard deviation. In reality, there are many statistical measures that can use Propanc Biopharma, historical prices to predict the future Propanc Biopharma,'s volatility.| Risk Adjusted Performance | (0.24) | |||
| Jensen Alpha | (2.36) | |||
| Total Risk Alpha | (3.23) | |||
| Treynor Ratio | 2.37 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Propanc Biopharma,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Propanc Biopharma, February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.24) | |||
| Market Risk Adjusted Performance | 2.38 | |||
| Mean Deviation | 5.14 | |||
| Coefficient Of Variation | (316.00) | |||
| Standard Deviation | 7.68 | |||
| Variance | 58.99 | |||
| Information Ratio | (0.33) | |||
| Jensen Alpha | (2.36) | |||
| Total Risk Alpha | (3.23) | |||
| Treynor Ratio | 2.37 | |||
| Maximum Drawdown | 58.21 | |||
| Value At Risk | (14.89) | |||
| Potential Upside | 7.14 | |||
| Skewness | 0.3761 | |||
| Kurtosis | 5.49 |
Propanc Biopharma Common Backtested Returns
Propanc Biopharma Common maintains Sharpe Ratio (i.e., Efficiency) of -0.26, which implies the firm had a -0.26 % return per unit of risk over the last 3 months. Propanc Biopharma Common exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Propanc Biopharma,'s Variance of 58.99, risk adjusted performance of (0.24), and Coefficient Of Variation of (316.00) to confirm the risk estimate we provide. The company holds a Beta of -1.03, which implies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Propanc Biopharma, are expected to decrease slowly. On the other hand, during market turmoil, Propanc Biopharma, is expected to outperform it slightly. At this point, Propanc Biopharma Common has a negative expected return of -2.01%. Please make sure to check Propanc Biopharma,'s potential upside and the relationship between the accumulation distribution and period momentum indicator , to decide if Propanc Biopharma Common performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.55 |
Modest predictability
Propanc Biopharma Common has modest predictability. Overlapping area represents the amount of predictability between Propanc Biopharma, time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Propanc Biopharma Common price movement. The serial correlation of 0.55 indicates that about 55.0% of current Propanc Biopharma, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.55 | |
| Spearman Rank Test | 0.57 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Propanc Biopharma, technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Propanc Biopharma Common Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Propanc Biopharma Common across different markets.
About Propanc Biopharma, Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Propanc Biopharma Common on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Propanc Biopharma Common based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Propanc Biopharma Common price pattern first instead of the macroeconomic environment surrounding Propanc Biopharma Common. By analyzing Propanc Biopharma,'s financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Propanc Biopharma,'s intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Propanc Biopharma, specific price patterns or momentum indicators. Please read more on our technical analysis page.
Propanc Biopharma, February 11, 2026 Technical Indicators
Most technical analysis of Propanc help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Propanc from various momentum indicators to cycle indicators. When you analyze Propanc charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.24) | |||
| Market Risk Adjusted Performance | 2.38 | |||
| Mean Deviation | 5.14 | |||
| Coefficient Of Variation | (316.00) | |||
| Standard Deviation | 7.68 | |||
| Variance | 58.99 | |||
| Information Ratio | (0.33) | |||
| Jensen Alpha | (2.36) | |||
| Total Risk Alpha | (3.23) | |||
| Treynor Ratio | 2.37 | |||
| Maximum Drawdown | 58.21 | |||
| Value At Risk | (14.89) | |||
| Potential Upside | 7.14 | |||
| Skewness | 0.3761 | |||
| Kurtosis | 5.49 |
Propanc Biopharma, February 11, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Propanc stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 47,232 | ||
| Daily Balance Of Power | (0.50) | ||
| Rate Of Daily Change | 0.95 | ||
| Day Median Price | 0.19 | ||
| Day Typical Price | 0.19 | ||
| Price Action Indicator | (0.01) |
Complementary Tools for Propanc Pink Sheet analysis
When running Propanc Biopharma,'s price analysis, check to measure Propanc Biopharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Propanc Biopharma, is operating at the current time. Most of Propanc Biopharma,'s value examination focuses on studying past and present price action to predict the probability of Propanc Biopharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Propanc Biopharma,'s price. Additionally, you may evaluate how the addition of Propanc Biopharma, to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |